NOAEL Studies
Cosmetic Ingredient
Dibutyl Sebacate NOAEL Studies
INCI: DIBUTYL SEBACATE
CAS: 109-43-3
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS_DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS_DB | NOAEL | 625 | mg/kg bw/day | rat | oral | 365 day | Chronic | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
| COSMOS_DB | NOAEL | 3125 | mg/kg bw/day | rat | oral | 730 day | Chronic | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
NTP_ICE_adme_parameters 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_adme_parameters | Clint | 134 | uL/min/10^6 cells | Human | - | - | Measured; httk, Human Hepatic Intrinsic Clearance | sheet=Data; excel_row=666; Record_ID=adme_parameters_967; Data_Type=Measured; DTXSID=DTXSID1041847; Assay=httk, Human Hepatic Intrinsic Clearance; Endpoint=Clint; Response=134.0; Response_Unit=ul/min/10^6 cells; Species=Human; Reference=httk2.3.1, Wambaugh 2019; URL=https://cran.r-project.org/web/packages/httk/index.html; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1041847 |
| NTP_ICE_adme_parameters | Fu | 7.05e-8 | fraction | Human | - | - | Measured; httk, Human Plasma Fraction Unbound | sheet=Data; excel_row=667; Record_ID=adme_parameters_967; Data_Type=Measured; DTXSID=DTXSID1041847; Assay=httk, Human Plasma Fraction Unbound; Endpoint=Fu; Response=7.05e-08; Response_Unit=Unitless Fraction; Species=Human; Reference=httk2.3.1, Wambaugh 2019; URL=https://cran.r-project.org/web/packages/httk/index.html; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1041847 |
NTP_ICE_endocrine 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_endocrine | Model Score | 0 | unitless | - | - | - | ARPathway2016; AR Pathway Model, Antagonist | sheet=Integrated_approaches; excel_row=7674; RecordID=ARPathway2016_527; DatasetName=ARPathway2016; DTXSID=DTXSID1041847; Assay=AR Pathway Model, Antagonist; Endpoint=Model Score; Response=0; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1041847 |
openFDA substances 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 4W5IH7FLNY | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C18H34O4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"4W5IH7FLNY"} |
| openFDA substances | FDA UNII substance identifier | 4W5IH7FLNY | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C18H34O4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"4W5IH7FLNY"} |
| openFDA substances | FDA UNII substance identifier | 4W5IH7FLNY | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C18H34O4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"4W5IH7FLNY"} |
| openFDA substances | FDA UNII substance identifier | 4W5IH7FLNY | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C18H34O4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"4W5IH7FLNY"} |